Matches in Nanopublications for { ?s ?p "[PF00299804 is a highly effective inhibitor of both the wild-type ERBB2 and the gefitinib-resistant oncogenic ERBB2 mutation identified in lung cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP97985.RAWE8CIUr-JLnZaGv8-aRiLRmKdQc7gzabF9R9JVeJy8M130_assertion description "[PF00299804 is a highly effective inhibitor of both the wild-type ERBB2 and the gefitinib-resistant oncogenic ERBB2 mutation identified in lung cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP97985.RAWE8CIUr-JLnZaGv8-aRiLRmKdQc7gzabF9R9JVeJy8M130_provenance.
- assertion description "[PF00299804 is a highly effective inhibitor of both the wild-type ERBB2 and the gefitinib-resistant oncogenic ERBB2 mutation identified in lung cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_assertion description "[PF00299804 is a highly effective inhibitor of both the wild-type ERBB2 and the gefitinib-resistant oncogenic ERBB2 mutation identified in lung cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_provenance.
- NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_assertion description "[PF00299804 is a highly effective inhibitor of both the wild-type ERBB2 and the gefitinib-resistant oncogenic ERBB2 mutation identified in lung cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232431.RAKYHbKgfcEV0_zlF8N3JA8appb3qLhzcI1yND_1aH-P0130_provenance.